These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25449496)

  • 1. Resistant or recurrent acute pericarditis: a new therapeutic opportunity?
    Massardier C; Dauphin C; Eschalier R; Lusson JR; Soubrier M
    Int J Cardiol; 2014 Dec; 177(2):e75-7. PubMed ID: 25449496
    [No Abstract]   [Full Text] [Related]  

  • 2. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.
    Lazaros G; Vasileiou P; Koutsianas C; Antonatou K; Stefanadis C; Pectasides D; Vassilopoulos D
    Ann Rheum Dis; 2014 Dec; 73(12):2215-7. PubMed ID: 25165036
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
    Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
    Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic relapsing acute pericarditis: Report of one case with favorable response to anakinra.
    Roque Rojas F; Mellor Pita S; Tutor de Ureta P
    Med Clin (Barc); 2018 Feb; 150(4):160. PubMed ID: 28919212
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment.
    Cantarini L; Lucherini OM; Cimaz R; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(5):802. PubMed ID: 21029567
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al.
    Brucato A; Imazio M; Spodick D; Adler Y
    Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
    Scardapane A; Brucato A; Chiarelli F; Breda L
    Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis.
    Negro E; Costedoat-Chalumeau N; Nivuori M; Gabiati C; Pallini G; Brucato A
    Can J Cardiol; 2023 Aug; 39(8):1152-1153. PubMed ID: 36306922
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent pericarditis: new and emerging therapeutic options.
    Imazio M; Lazaros G; Brucato A; Gaita F
    Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy.
    Shaukat MH; Singh S; Davis K; Torosoff M; Peredo-Wende R
    Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):888-892. PubMed ID: 32159368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
    Dagan A; Langevitz P; Shoenfeld Y; Shovman O
    Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.
    Parizo JT; Moayedi Y; Nieman K; Town K; Teuteberg JJ; Khush KK
    Clin Transplant; 2019 Oct; 33(10):e13699. PubMed ID: 31437316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Lupus Pericarditis Treated with Anakinra - a Case Report.
    Oliveira Pinheiro F; Seabra Rato M; Madureira P; Paiva M; Costa L
    ARP Rheumatol; 2022; 1(4):334-335. PubMed ID: 36617317
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
    Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
    J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incessant Pericarditis Successfully Treated With Anakinra in a Patient on Active Treatment for Mediastinal Lymphoma.
    Camilli M; Viscovo M; Hohaus S; Lamendola P; Verrecchia E; Gerardino L; Crea F; Lombardo A; Manna R
    Can J Cardiol; 2023 Aug; 39(8):1154-1157. PubMed ID: 36334641
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-1 blockade for recurrent pericarditis: insights from the real-world experience.
    Lazaros G; Tsioufis K; Vassilopoulos D
    J Pediatr; 2023 Jul; 258():113354. PubMed ID: 36963480
    [No Abstract]   [Full Text] [Related]  

  • 19. Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.
    Gattringer R; Lagler H; Gattringer KB; Knapp S; Burgmann H; Winkler S; Graninger W; Thalhammer F
    Eur J Clin Invest; 2007 Nov; 37(11):912-4. PubMed ID: 17973784
    [No Abstract]   [Full Text] [Related]  

  • 20. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.
    Karadeniz H; Yamak BA; Özger HS; Sezenöz B; Tufan A; Emmi G
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):883-885. PubMed ID: 32734502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.